Physician profile
Amy E Kubler
NPI 1841712957
$2,343.55
in general payments reported to CMS, 2019-2025
16 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.98 · 2022: $383 · 2023: $658 · 2024: $965 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $503.23 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $502.42 | 2022-2025 | |
| Novo Nordisk INC | $278.04 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $265.64 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $242.05 | 2023-2025 | Repatha, Otezla, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $153.25 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $75.45 | 2023-2025 | Rexulti |
| Pfizer INC. | $71.41 | 2023-2024 | |
| Exact Sciences Corporation | $54.34 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.85 | 2023-2024 | Jardiance |
| Abbott Laboratories | $49.73 | 2022-2024 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $26.86 | 2025 | Auvelity |
| Amarin Pharma, INC. | $21.27 | 2021 | |
| Vanda Pharmaceuticals INC. | $18.97 | 2024 | Fanapt |
| Bayer Healthcare Pharmaceuticals INC. | $15.69 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kubler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.